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Background: Clopidogrel low response correlates with poor prognosis
after percutaneous coronary intervention (PCI). It is today clearly demon-
strated that there is a large inter-individual variability in clopidogrel response.
Some authors also suggest intra-individual variability over time. We assessed
the impact of initial clinical presentation on clopidogrel low response.
Methods: In this prospective study, clopidogrel response was assessed in
100 patients following PCI: 50 presented with acute coronary syndrome (ACS
group) and 50 patients with stable coronary disease were matched 1 to 1 on
age, sex, BMI and diabetes (stable group). All patients were tested between
18h and 24h after a 600mg clopidogrel loading dose using the test of Veri-
fyNow-P2Y12 (results expressed as PRU). Patients under chronic clopidogrel
therapy or treated with GpIIb-IIIa inhibitors were excluded.
Results: The mean age was 61±12 in each group. Altogether, 28% patients
were diabetics in each group and the mean BMI was 27.6±5.6 and 27.9±5.9
in the ACS group and stable group, respectively (p=ns). The mean PRU
values were 159±94 and 197±80 in the ACS group and stable group, respec-
tively (p=0.033). By multivariate analysis, “ACS group” was significantly
associated with higher PRU value (p=0.018) (see Table).
Conclusion: The present study suggests – firstly – that initial clinical pre-
sentation (especially ACS) is a strong predictor of clopidogrel low response –
and secondly – an intra-individual variability over time. These results are in
accordance with recent trials showing a benefit of increased antiplatelet
therapy in ACS patients.
Table – Predictors of clopidogrel low response
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Interest of the analysis of heart rate recovery during a stress test, in
order to promote the physical activity of diabetic women in Algiers
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Regular exercise has ever been recomanded for diabetic patients. Among
the tests that allow the detection of silent ischemia (SI), the exercise test (ET)
retains a special place for women because of its negative predictive value, this
test also allows the analysis of heart rate recovery (HRR), studied in particular
female populations. The calculation to one minute with a threshold of 22 bt/mn
is an important predictor of death. Our goal is to use this factor to encourage
the practice of a regular physical exercise and that the “old lady” what exer-
cise testing has a place in the management of diabetes despite the results of
the DIAD study.
Methods: This is a descriptive study of HRR, as part of a search for SI,
200 sedentary women with diabetes, including diabetes type 1 and 2 is seen
on average for 14,5 years (range 12 months-30 years), mean age 56 years,
which sometimes combine four risk factors, including:hypertension (80%),
menopause (81%),overweight (39%) or obese (43%),but mostly a waist of
about 100 to 110 in 61% and even higher than 120 cm, hypothyroidism was
found in 19%.The ET was carried out on a treadmill according to Bruce pro-
tocol in all cases the theoretical maximum frequency was reached, exercise
capacity and the HRR was evaluated in the first minute and at the end of the
test.
Results: There were no statistical correlations between a sub ST elevation
and the balance of diabetes (HbA1c) and poor HRR. Exercise capacity
(METS) was low <6 in 18.5%, between 6 and 9 (38%), 10-13 (30.5%) and
>13 (23%). HRR in the 1st min 22 bt/mn in 52% and <to 22 bt/mn in 48%,
the total recovery is only achieved in 35% of cases.
Conclusion: The weakness of the HRR in this diabetic population may be
explained by physical inactivity, poor diabetes control, itself probably related
to cardiac autonomic neuropathy. The screening with exercise test in women,
encourage them to practice a regular physical activity.
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Objective: The purpose of this study is to assess the predictors factors of
severe coronary artery disease defined by a syntax score over 32 points of
patients hospitalized for acute coronary syndrome in a single Algerian center
study.
Materials and Methods: This is a prospective, multivariate study, per-
formed in the cardiology department of the Beni Messous hospital, near
hospitalized patients for acute coronary syndrome, from 1 January 2010 to
30 decembre 2011.
A number of 303 patients is included, 232 men (76.6%) and 71 women
(23.4%) aged between 22 to 86 years with an average age of 60.80 years, with
198 sca + (65.3%) (83.8% men, 16.2% women) and 105 sca- (34.7%) (62.85%
male, 37.15% female).
Patients were classified into 02 groups: one group with a lower syntax
score than 33 points: 263 patients and a group with a score above 33 points:
40 patients
Categorical
Variables
Continuous
Variables
Univariate
analysis
Multivariate
analysis
mean PRU Correlation r p p
Clinical
Présentation
Stable group
ACS group
159
197
0,033 0,018
Age 0,283 0,004 0,076
Sex
Male
Female
202
167
0,068 0,207
BMI 0,215 0,033 0,026
Tabac
No
Yes
155
205
0,005 0,536
Diabetes
No
Yes
205
167
0,060 0,684
Renal failure
No
Yes
174
216
0,182 0,775
PPI
No
Yes
202
167
0,075 0,418
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Results: In univariate analysis : The only significant variables between the
02 groups are: age, diabetes, smoking, clearance of creat.
In multivariate analysis, two significant variables: diabetes, the creatinine
clearance.
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Ascorbic acid prevents contrast-mediated nephropathy in patients
undergoing coronary angiography
Sonia Hamdi, Aymen Elhraiech, Mahdi Chakroun, Talel Trimech, Walid
Jomaa, Wiem Selmi, Khaldoun Ben Hamda, Faouzi Maatouk
CHU Fattouma Bourguiba, Cardiologie B, Monastir, Tunisie
Background: Radiocontrast nephropathy is associated with increased mor-
bidity and mortality, particularly in patients with percutaneous coronary inter-
ventions. A number of agents that improve renal circulation have been
clinically tested for prevention of radiocontrast nephropathy, but none of them
has succeeded. Protection of renal tubular cells against oxidative stress is
another approach to avoid radiocontrast nephropathy. Prophylactic effects of
antioxidants such as N-acetylcysteine have been reported by several investiga-
tors, although the effectiveness of these compounds is still a matter of debate.
Ascorbic acid, an antioxidant agent, a safe and not expensive medication,
could be used to prevent radiocontrast nephropathy.
Methods: We conducted a randomized, double-blind, placebo-controlled
trial of ascorbic acid in 202 patients who underwent coronary angiography
and/or intervention. The patients were randomly assigned to receive either oral
Vitamin C (3 g at least 2 hours before the procedure and 2 g in the night and
the morning after the procedure) or placebo, in adjunct to hydration. Serum
creatinine was measured prior to and 48h after coronary angiography. The pri-
mary end-point was the occurrence of CIN, defined as an increase in serum
creatinine ≥0.5 mg/dL (44.2 μmol/L) or ≥25% above baseline at 48h after
exposure to contrast medium.
Results: Complete data on the outcomes were available on 202 patients,
107 of whom had received Vitamine C. There were no significant differences
between the Vitamin C and placebo groups in baseline characteristics, amount
of hydration, or type and volume of contrast used. CIN occurred in 11 out of
107 (10.3%) patients in the Vitamin C group and 20 out of 95 (21.1%)
patients in the placebo group (P=0.032).
Conclusion: There was detectable benefit for the prophylactic administra-
tion of oral Vitamin C over an aggressive hydration protocol in patients
Undergoing Coronary Angiography or Intervention.
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Silent myocardial ischemia and diabetes: to screen or not to screen!
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Background: A common argument for identifying SMI in asymptomatic
diabetic patients is to intensify treatment of risk factors and to propose a cor-
onarography for eventual revascularization. However, published data demon-
strating that a prospectively applied screening program improves outcome in
asymptomatic diabetic patient are still lacking.
Aim: Our objective was to determine if patients with SMI+ and coronar-
ography have a better survival than the patients with SMI who did not undergo
coronagraphy.
Methods and results: In our department, we used to screen for SMI in high
risk diabetic patients, following international recommendations. All patients
benefit of treatment of their risk factors following international guidelines.
Since 2000, 913 high risk diabetic patients with normal baseline electro-
cardiography were evaluated to identify patients with SMI, using myocardial
perfusion imaging. SMI prevalence was 18%. Coronarography was done in
94 patients SMI+. There was no difference regarding risk factors between the
group who underwent coronarography and the one who did not. These patients
were followed during a mean period of 6,5 years. Survival analysis was made
for univariate analysis, using Kaplan Meyer methods. Covariables with p-
value < 0.15 at log-rank test were introduced in COX multivariate analysis.
Significant variables were selectioned for final model selection through STEP-
WISE, BACKWARD, FORWARD methods.
79 patients died (8,6%), mainly from cardiovascular diseases (84%). In
univariate analysis, presence of SMI was not associated with total mortality
(p=0,2263) nor cardiovascular mortality (p=0,57). Furthermore, in the group
of patients SMI+, coronarography was not associated with a better survival in
multivariate analysis.
Conclusion: This observational study should argue for intensive cardiovas-
cular risk factors treatment in diabetes in reducing cardiovascular mortality,
with no argument for a benefit from SMI screening
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Incidence and predictors of bleeding complications in diabetic
patients during long-term follow-up after DES implantation
Vassilis Voudris, Panagiotis Karyofyllis, Constantinos Doulaptsis, Ioannis
Moukas, Sophia Thomopoulou, Dennis Cokkinos
Onassis Cardiac Surgery Centre, Athens, Grèce
Background: We investigate the frequency, correlates, and clinical signif-
icance of bleeding complications in diabetic patients (pts) with long-term dual
antiplatelet treatment (DAPLT) after drug-eluting stent (DES) implantation.
Methods: We assessed 610 consecutive diabetic pts (male 80%, mean age
65±9 years) after DES implantation. Five years clinical follow-up (FU),
Variable P- value
AGE 0.030
SEX NS
HTA NS
DIABETES 0.007
SMOKING 0.011
TYPE OF ACS 0.01
BMI NS
CLEARANCE 0.0002
HDL NS
LDL NS
CT NS
TG NS
FE NS
Effect Criteria effect model fit 
tests likelihood ratios
Likelihood ratios tests
2 Log likelihood 
of the model chi-square
chi-deux degrees 
of freedom
Signif.
Constante 92.885 (a) .000 0 .
Smoking 93.919 1.034 1 0.309
Diabetes 97.049 4.164 1 0.041
Age group 99.702 6.817 6 0.338
cclear 100.610 7.725 2 0.021
Type sca 94.859 1.974 1 0.160
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